Connelly Deirdre P — SEC Form 4 filings
SEC reporting owner CIK 1303417. 16 Form 4 filings on record with FilingPulse; latest filed 2026-07-02.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-04-02 to 2026-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| LINCOLN NATIONAL CORP (LNC) | Director | 10 | — | — | 10 |
| Sarepta Therapeutics, Inc. (SRPT) | Director | 3 | — | — | 5 |
| Macy's, Inc. (M) | Director | 3 | — | — | 3 |
Form 4 filings — Connelly Deirdre P
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-02 | 4 | LINCOLN NATIONAL CORP (LNC) | Grant/award (A): 1,272.98 (derivative) @ $35.35 | EDGAR |
| 2026-06-08 | 4 | Macy's, Inc. (M) | Grant/award (A): 8,348 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Grant/award (A): 16,875 | EDGAR |
| 2026-04-02 | 4 | LINCOLN NATIONAL CORP (LNC) | Grant/award (A): 1,267.61 (derivative) @ $35.50 | EDGAR |
| 2026-01-05 | 4 | LINCOLN NATIONAL CORP (LNC) | Grant/award (A): 1,010.55 (derivative) @ $44.53 | EDGAR |
| 2025-10-02 | 4 | LINCOLN NATIONAL CORP (LNC) | Grant/award (A): 1,115.79 (derivative) @ $40.33 | EDGAR |
| 2025-07-02 | 4 | LINCOLN NATIONAL CORP (LNC) | Grant/award (A): 1,300.58 (derivative) @ $34.60 | EDGAR |
| 2025-06-03 | 4 | Macy's, Inc. (M) | Grant/award (A): 13,456 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | LINCOLN NATIONAL CORP (LNC) | Grant/award (A): 1,253.13 (derivative) @ $35.91 | EDGAR |
| 2025-03-11 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Grant/award (A): 2,383 · Grant/award (A): 4,792 (derivative) @ $0 | EDGAR |
| 2025-01-02 | 4 | LINCOLN NATIONAL CORP (LNC) | Grant/award (A): 1,419.11 (derivative) @ $31.71 | EDGAR |
| 2024-10-02 | 4 | LINCOLN NATIONAL CORP (LNC) | Grant/award (A): 1,428.12 (derivative) @ $31.51 | EDGAR |
| 2024-09-16 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Grant/award (A): 2,842 @ $0 · Grant/award (A): 6,442 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | LINCOLN NATIONAL CORP (LNC) | Grant/award (A): 1,446.95 (derivative) @ $31.10 | EDGAR |
| 2024-05-20 | 4 | Macy's, Inc. (M) | Grant/award (A): 8,209 (derivative) @ $0 | EDGAR |
| 2024-04-02 | 4 | LINCOLN NATIONAL CORP (LNC) | Grant/award (A): 1,409.33 (derivative) @ $31.93 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1303417 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →